Albemarle Idles Kemerton Plant’s Last Train, Targets EBITDA Boost in Q2 2026
Albemarle will idle Train 1 at its Kemerton lithium hydroxide plant immediately, halting all processing operations after previously suspending Train 2 and cancelling Trains 3 and 4 expansions. This cost-cutting measure preserves 2026 sales volume forecasts and targets improved adjusted EBITDA flexibility from Q2 2026.
1. Idling Decision and Background
Albemarle has placed the sole operating line, Train 1, at its Kemerton lithium hydroxide processing plant into care and maintenance effective immediately. This follows the 2024 suspension of Train 2 operations and the cancellation of planned Trains 3 and 4 expansions, leaving the facility fully idled.
2. Financial Implications and Outlook
The shutdown aims to reduce high conversion costs at the Western Australia site during periods of price volatility. Management expects the move to preserve projected 2026 sales volumes while providing greater adjusted EBITDA flexibility beginning in Q2 2026.
3. Impact on Broader Operations
Albemarle’s upstream interests, including its 50% Greenbushes offtake rights and Wodgina mining stake, remain operational and central to its lithium strategy. Regional exploration assets are also unaffected, ensuring continued exposure to Australia’s premier spodumene deposits.